Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37462578)
Watch
English
Benefits and risks of interferon therapy for hepatitis B.
scientific article published on May 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
title
Benefits and risks of interferon therapy for hepatitis B.
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
author name string
Robert Perrillo
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
language of work or name
English
0 references
publication date
1 May 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
volume
49
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
issue
5 Suppl
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
page(s)
S103-11
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
cites work
Immune responses in hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatitis B: 2000--summary of a workshop
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune effects of alpha-interferon in chronic liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pilot study of recombinant human alpha-interferon for chronic type B hepatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of hepatitis B -- viral suppression or eradication?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.22956
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.22956
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
PubMed ID
19399806
1 reference
stated in
Europe PubMed Central
PubMed ID
19399806
retrieved
20 August 2017
ResearchGate publication ID
24366802
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
